Mycophenolate mofetil and Cerebral disorder - a phase IV clinical study of FDA data

Summary:

Cerebral disorder is reported as a side effect among people who take Mycophenolate mofetil (mycophenolate mofetil), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Vitamin D3, and have Hyperuricaemia.

The phase IV clinical study analyzes which people have Cerebral disorder when taking Mycophenolate mofetil. It is created by eHealthMe based on reports of 93,176 people who have side effects when taking Mycophenolate mofetil from the FDA, and is updated regularly.

What is Mycophenolate mofetil?

Mycophenolate mofetil has active ingredients of mycophenolate mofetil. It is often used in myasthenia gravis. eHealthMe is studying from 93,460 Mycophenolate mofetil users. Check the latest studies of Mycophenolate mofetil.

What is Cerebral disorder?

Cerebral disorder (brain disease) is found to be associated with 657 drugs and 683 conditions by eHealthMe. Check the latest studies of Cerebral disorder.

On Jul, 13, 2026

93,176 people reported to have side effects when taking Mycophenolate mofetil.
Among them, 35 people (0.04%) have Cerebral disorder.

Could Mycophenolate mofetil cause Cerebral disorder?

Among these 35 people:

How long have people been on Mycophenolate mofetil when they have Cerebral disorder? *

What is the gender of people who have Cerebral disorder when taking Mycophenolate mofetil? *

female: 70 %
male: 30 %

What is the age of people who have Cerebral disorder when taking Mycophenolate mofetil? *

What are other drugs people take besides Mycophenolate mofetil? *

Vitamin D3: 15 people, 42.86%
Escitalopram: 14 people, 40.00%
Zopiclone: 14 people, 40.00%
Biotin: 14 people, 40.00%
Prednisone: 12 people, 34.29%
Hydroxychloroquine Sulfate: 10 people, 28.57%
Lysine: 10 people, 28.57%
Omeprazole: 10 people, 28.57%
Naproxen: 10 people, 28.57%
Azathioprine: 10 people, 28.57%

What are other side effects people have besides Cerebral disorder? *

Hair Loss: 16 people, 45.71%
Rashes (redness): 15 people, 42.86%
Pigmentation Disorder (disturbances of human skin colour): 14 people, 40.00%
Muscle Atrophy (a decrease in the mass of the muscle): 14 people, 40.00%
Dyspnea (difficult or laboured breathing): 9 people, 25.71%
Weakness: 8 people, 22.86%
Idiopathic Or Primary Livedo Reticularis (netlike pattern of reddish-blue skin discoloration, usually on the legs): 7 people, 20.00%
Inflammation: 7 people, 20.00%
Heart Rate Increased: 7 people, 20.00%
Drug Ineffective: 7 people, 20.00%

What are the existing conditions these people have? *

Hyperuricaemia (level of uric acid in the blood that is abnormally high): 4 people, 11.43%
Gouty Arthritis (joint inflammation with crystal formation): 3 people, 8.57%
Uveitis (inflammation of the uvea): 2 people, 5.71%
Stress And Anxiety: 2 people, 5.71%
Retinopathy Proliferative (a condition in which very small blood vessels grow from the surface of the retina and damages retina): 2 people, 5.71%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 5.71%
High Blood Cholesterol: 2 people, 5.71%
Dyspnea (difficult or laboured breathing): 2 people, 5.71%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 2.86%
Pneumonia: 1 person, 2.86%

* Approximation only. Some reports may have incomplete information.

Do you take Mycophenolate mofetil and have Cerebral disorder?

- Check whether Cerebral disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mycophenolate mofetil:

Mycophenolate mofetil (93,460 reports)

Browse all side effects of Mycophenolate mofetil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cerebral disorder:

Cerebral disorder (657 drugs)

Browse all the conditions that are associated with Cerebral disorder:

Cerebral disorder (683 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mycophenolate mofetil (the active ingredients of Mycophenolate mofetil) and Mycophenolate mofetil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.